课题基金 / 基金详情

Cell Survival and Cancer

Cell Survival and Cancer
细胞存活与癌症
批准号:
6708169
负责人:
BRUNO CALABRETTA
金额:
$129.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-06-01 至 2008-05-31

项目摘要

项目成果

BRUNO CALABRETTA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This multidisciplinary program focuses on the molecular mechanisms whereby oncoproteins, tyrosine kinase receptors and tumor suppressor genes regulate cell survival. The program has four projects. There is also a request for an administrative and a nucleic acids core component.The investigators intend to study: i) the mechanisms and the significance of enhanced MDM2 levels in BCR/ABL-expressing cells and BCR/ABL-dependent leukemogenesis, the mechanisms whereby BCR/ABL suppresses C/EBPalpha expression and the biological consequences of restoring C/EBPalpha expression in BCR/ABL cells; ii) the mechanisms whereby the IGF-1 receptor promotes the localization of IRS-1 in the nucleus, the regulation of IRS-1 expression and promoter activity by IGF-1R and STAT-3, and the role of IRS-1, Id2, pRb, and STAT-3 in IGF-1-mediated regulation of apoptosis, proliferation and differentiation; iii) the pro-apoptotic effects involved in tumor suppression by the Fhit gene and the role of Fhit loss of function in tumorigenesis; iv) the role of the newly identified mitochondrial serine proteinase, Omi, in caspase-dependent and caspase-independent apoptosis and the involvement of the ER-localized GSPT-1 protein in the ER stress-induced apoptosis. The long-term objective of this Program Project is to utilize this information as a molecular basis for devising more rational approaches to anti-cancer therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel strategy for transcriptional reprogramming of lymphoid leukemia cells
  • 批准号:
    10392174
  • 项目类别:
  • 资助金额:
    $54.0万
  • 财政年份:
    2022
  • 负责人:
    BRUNO CALABRETTA
  • 依托单位:
A novel strategy for transcriptional reprogramming of lymphoid leukemia cells
  • 批准号:
    10543999
  • 项目类别:
  • 资助金额:
    $52.92万
  • 财政年份:
    2022
  • 负责人:
    BRUNO CALABRETTA
  • 依托单位:
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
  • 批准号:
    10437005
  • 项目类别:
  • 资助金额:
    $61.87万
  • 财政年份:
    2021
  • 负责人:
    BRUNO CALABRETTA
  • 依托单位:
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
  • 批准号:
    10317798
  • 项目类别:
  • 资助金额:
    $64.53万
  • 财政年份:
    2021
  • 负责人:
    BRUNO CALABRETTA
  • 依托单位:
海外基金